MyAverix Finance MyAverix Finance

KQ · Healthcare

OliX PharmaceuticalsInc (226950)

Biotechnology

OliX PharmaceuticalsInc (226950) is listed on KQ in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-24

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for 226950

P/E ratio
25.00

OliX PharmaceuticalsInc (226950) — FAQ

What is 226950's P/E ratio?

The price-to-earnings (P/E) ratio for OliX PharmaceuticalsInc (226950) is 25.00 (data as of 2026-05-24).

Does OliX PharmaceuticalsInc pay a dividend?

Dividend yield is not available in the current snapshot for OliX PharmaceuticalsInc (226950). Check the MyAverix Finance app for the latest dividend data.

What sector is OliX PharmaceuticalsInc in?

OliX PharmaceuticalsInc (226950) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 226950 listed on?

226950 is listed on KQ.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play